Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$2K Buy
+100
New +$2.4K ﹤0.01% 10014
2014
Q2
Sell
-886
Closed -$21K 10776
2014
Q1
$21K Sell
886
-3,914
-82% -$95.2K ﹤0.01% 8024
2013
Q4
$121K Sell
4,800
-614
-11% -$14.5K ﹤0.01% 5855
2013
Q3
$125K Buy
5,414
+3,843
+245% +$87.5K ﹤0.01% 5760
2013
Q2
$32K Buy
+1,571
New +$29.8K ﹤0.01% 7313

Other funds holding SNV

UBS's SNV Position: Q3 2014 in Review

UBS reduced its Synovus (SNV) stake by 18% in Q3 2014, selling an estimated $539K and leaving 105,052 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2698.

UBS first reported a position in SNV in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.11M in Q2 2014. 235 funds tracked by Wall St. Rank hold SNV as of Q3 2014.

  • UBS held 105,052 shares of Synovus worth $2.48M as of Q3 2014.
  • UBS sold 22,497 Synovus shares in Q3 2014, an estimated $539K.
  • Synovus made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2698 holding.
  • UBS first reported a position in Synovus in Q2 2013 and has held it in 6 quarters since.
  • UBS's Synovus position peaked at $3.11M in Q2 2014.
  • 235 funds tracked by Wall St. Rank held Synovus as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.